Dawn McCollough has overseen global clinical development involving thousands of patients across numerous indications for nearly 25 years. In addition to her role at MAPS PBC, she owns a consulting company that assists pharmaceutical, biotech and CRO clients.
Previously, she headed clinical operations functions in start-up Biotech organizations, headed Medical Research Operations and Research Team in Late Stage Development at Biogen. Prior to that, Dawn was Head of the Global Monitoring Organization for North America at Novartis Vaccines and Diagnostics, based in Cambridge, MA. Dawn began her career with Novartis as Global Head of Clinical Trial Governance based in Siena, Italy. Throughout the course of her career, she has participated in the development of numerous drug products from concept to approval. Dawn has been chosen as a top Women’s Leader within previously affiliated organizations.
Dawn has an entrepreneurial spirit and is passionate about developing new options for patients and for people. Dawn enjoys ultra running and has a very strong connection with animals, and anything outdoors.